Nippon Chemiphar Co., Ltd. (TYO:4539)
Japan · Delayed Price · Currency is JPY 1,666.00
-4.00 (-0.24%)
May 8, 2026, 12:30 PM JST
Nippon Chemiphar Market Cap
Nippon Chemiphar has a market cap or net worth of 6.01 billion as of May 8, 2026. Its market cap has increased by 17.15% in one year.
Market Cap
6.01B
Enterprise Value
16.67B
Revenue
32.52B
Ranking
n/a
PE Ratio
11.03
Stock Price
1,666.00
Market Cap Chart
Since January 14, 1992, Nippon Chemiphar's market cap has decreased from 34.36B to 6.01B, a decrease of -82.51%. That is a compound annual growth rate of -4.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 6.01B | 5.11% |
| Dec 30, 2025 | 5.72B | 4.27% |
| Dec 30, 2024 | 5.48B | -3.80% |
| Dec 29, 2023 | 5.70B | -4.67% |
| Dec 30, 2022 | 5.98B | -17.63% |
| Dec 30, 2021 | 7.26B | -8.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 18.77B |
| Pharma Foods International | 17.95B |
| Taiko Pharmaceutical | 14.67B |
| Wakamoto Pharmaceutical | 12.42B |
| Morishita Jintan | 9.04B |
| Solasia Pharma K.K. | 8.74B |
| Cyfuse Biomedical K.K. | 6.75B |
| SymBio Pharmaceuticals | 6.53B |